- Home
- OSPN vs CRMD Comparison
OSPN vs CRMD Comparison
Compare OSPN & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSPN
- CRMD
- Stock Information
- Founded
- OSPN 1991
- CRMD 2006
- Country
- OSPN United States
- CRMD United States
- Employees
- OSPN N/A
- CRMD N/A
- Industry
- OSPN EDP Services
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- OSPN Technology
- CRMD Health Care
- Exchange
- OSPN Nasdaq
- CRMD Nasdaq
- Market Cap
- OSPN 702.8M
- CRMD 738.4M
- IPO Year
- OSPN 1998
- CRMD 2010
- Fundamental
- Price
- OSPN $19.32
- CRMD $12.38
- Analyst Decision
- OSPN Strong Buy
- CRMD Strong Buy
- Analyst Count
- OSPN 5
- CRMD 6
- Target Price
- OSPN $16.50
- CRMD $15.67
- AVG Volume (30 Days)
- OSPN 320.2K
- CRMD 1.3M
- Earning Date
- OSPN 02-27-2025
- CRMD 03-11-2025
- Dividend Yield
- OSPN N/A
- CRMD N/A
- EPS Growth
- OSPN N/A
- CRMD N/A
- EPS
- OSPN 0.75
- CRMD N/A
- Revenue
- OSPN $244,936,000.00
- CRMD $12,262,234.00
- Revenue This Year
- OSPN $4.28
- CRMD N/A
- Revenue Next Year
- OSPN $3.43
- CRMD $246.41
- P/E Ratio
- OSPN $25.45
- CRMD N/A
- Revenue Growth
- OSPN 7.05
- CRMD 41184.20
- 52 Week Low
- OSPN $9.22
- CRMD $2.89
- 52 Week High
- OSPN $19.58
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- OSPN 59.90
- CRMD 69.85
- Support Level
- OSPN $18.63
- CRMD $11.74
- Resistance Level
- OSPN $19.42
- CRMD $13.09
- Average True Range (ATR)
- OSPN 0.52
- CRMD 0.70
- MACD
- OSPN 0.01
- CRMD 0.38
- Stochastic Oscillator
- OSPN 92.55
- CRMD 87.17
About OSPN OneSpan Inc.
OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.